SEMA5A and pachyonychia congenita: In this present study, we determined the prospects of SEMA5A as a potential therapeutic target for PC by analyzing the pattern of SEMA5A expression in both human and murine PC tissues of the primary tumor as well as metastasis, and normal pancreas and its functional role in PC.